Advances in diagnostic devices in melanoma screening

Importance of oncology nurses' work and research to cancer care

Investigating anticarcinogenic compounds as an alternative to chemo

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma